Wonwoo Jeong, PhD
Research Fellow,
Wake Forest Institute for Regenerative medicine, NC
Biomedical engineer, specializing in 3D bioprinting, tissue engineering, and translational regenerative medicine.
Research has focused on
-Developing clinically relevant bio-inks for personalized tissue/organ manufacturing
-High throughput drug screening of patients-derived cancer organoids with tumor microenvironment
-Maturation of iPSC-derived organoids/ composite tissue
-AI-based diagnosis for tissue/organ equivalents
Research Interests
My research deeply focused translational regenerative medicine, with a strong emphasis on interdisciplinary application in 3D bioprinting.
Through joint projects with surgeons, anesthesiologists, and orthopedists, I have developed clinically relevant bio-inks, engineered artificial organ systems, and established patient-derived disease models. These collaborations have enabled the translation of bioprinting technologies into preclinical and clinical applications, fostering innovations that directly address unmet medical needs
Peer-reivewed Publications
Jeong et al., Clinically Relevant and Precisely Printable Live Adipose Tissue–Based Bio‐Ink for Volumetric Soft Tissue Reconstruction.
Advanced Healthcare Materials (2025)
Jeong et al., A bio-printed breast cancer-adipose intact tissue model mimicking distance-dependent paracrine interaction to evaluate chemo- and adipokines-targeted therapies. Advanced Healthcare Materials (2025)
Lee and Jeong et al., 3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications.
Advanced Materials (2024)